Tempus raised the lower end of its full-year revenue guidance to $1.60 billion from $1.595 billion.The company’s data ...
Rivian Automotive (RIVN) was in focus on Monday after UBS upgraded the stock to ‘Buy’ from ‘Neutral,’ while maintaining its ...
Marvell (MRVL) on Monday announced a $115 billion all-stock deal to acquire Lumentum (LITE), with Marvell CEO Matt Murphy ...
Apple (AAPL) earnings on Monday, Tuesday’s midterm elections and Friday’s jobs report will test whether last week’s AI ...
Check Point Software Technologies (CHKP) shares plunged as much as 9% in Monday's premarket trading after the cybersecurity ...
Cipher Digital (CIFR) shares took the biggest price-target cut on Monday in a sector-wide reset by Keefe Bruyette, which ...
Coinbase (COIN) shares edged lower in early-morning trade on Monday, as analysts offered a mixed outlook for the stock ...
Yardeni Research President Ed Yardeni said Monday that the recent artificial intelligence (AI) sell-off was not a full-blown ...
Alphabet, Inc. (GOOGL) shares rose 1% in premarket trading on Monday amid a relief recovery in tech stocks after a brutal ...
Regeneron and Alnylam’s Cemdisiran showed significant improvements in daily functioning and muscle strength in a Phase 3 ...
AstraZeneca emphasized ADC combinations, cell therapies and internally developed cancer vaccines as key oncology priorities.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results